Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited announced today that a Notice of Allowance has been received from the European Patent Office (EPO) for a patent application covering its proprietary Cymerus™ mesenchymal stem cell technology. The patent … Continue reading Cynata Therapeutics Receives Notice of Allowance from EPO for Patent Application
OncoSil Medical Ltd, a medical device company focused on localised treatments for patients with pancreatic and liver cancer, today released its Appendix 4C – Quarterly Cashflow report for the quarter ended 31 March 2018 (the Quarter or 3Q 18). All … Continue reading Oncosil Medical Reports Positive Cash Flow of $5.53m for the March 2018 Quarter
Sirtex Medical Limited (ASX:SRX) announced the Australian Foreign Investment Review Board (FIRB) has decided that the Commonwealth of Australia has no objection to Varian Medical Systems, Inc. (Varian) either directly or through one or more interposed wholly-owned subsidiaries acquiring up … Continue reading Sirtex Medical Provides Update on Scheme of Arrangement FIRB Approval
Sticky post
Cann Group Limited (ASX: CAN) has been granted import permits by the drug control section of the Therapeutic Goods Administration (TGA) that enables the company to commence the import of genetics and cannabis oils from its Canadian partners. The receipt … Continue reading Cann Group Announces Receipt of Import Permits for Genetics and Cannabis Oil
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Estonia. The Republic of Estonia Agency of Medicines issued the Marketing Authorisation on 13 February 2018. MVP CEO, Mr. John Sharman said, … Continue reading Medical Developments International Announces Penthrox Approved in Estonia
AusCann continues to demonstrate strong operational momentum with the granting of the final licence required for operations in Tasmania, the approval in Chile to plant its second crop, and post the quarter, an agreement with API to establish Australia wide … Continue reading AusCann Provides Quarterly Report for December 2017
MMJ PhytoTech Limited (ASX: MMJ) advised that it has entered into an agreement to acquire a strategic stake in private, Canadian-based healthcare company Dosecann Inc., via the proposed placement of C$2.5 million in secured convertible debenture units . Strategically, the … Continue reading MMJ Phytotech Announces Acquition of Strategic Position in Dosecann Inc
AusCann Group Holdings Ltd (ASX:AC8) announced that it has entered into a Heads of Agreement (HoA) with ASX listed Australian Pharmaceutical Industries Limited (ASX:API) to form a wholesale agreement for the distribution of AusCann’s cannabinoid medicines throughout Australia. The collaboration … Continue reading AusCann Group Holdings Signs HoA with Leading Wholesale Distributor in Australia
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Iceland. The Icelandic Medicines Agency issued the Marketing Authorisation on 16 January 2018 making Penthrox available for sale effective immediately. MVP CEO, … Continue reading Medical Developments International Announces Penthrox Approved in Iceland
Australian Pharmaceutical Industries today said that it expected its half year net profit after tax (NPAT) for the period ending 28 February 2018 will be approximately $26.5 million, and that full year NPAT is expected to be marginally above that … Continue reading Australian Pharmaceutical Industries Provides Trading Update
